AI
Thursday, February 23, 2012 3:31:35 PM
VRTX Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free
http://www.biomedreports.com/2012022389941/vertex-announces-12-week-on-treatment-data-and-svr4-from-phase-2-study-of-interferon-free-all-oral-treatment-regimen-of-incivek®-vx-222-and-ribavirin-in-people-with-genotype-1-hepatitis.html
http://www.biomedreports.com/2012022389941/vertex-announces-12-week-on-treatment-data-and-svr4-from-phase-2-study-of-interferon-free-all-oral-treatment-regimen-of-incivek®-vx-222-and-ribavirin-in-people-with-genotype-1-hepatitis.html
My own picks & mentions on Windowe.
http://bit.ly/Aq0Nn2
More Than [60] DD Picks on HOSS TRACKZ.
http://bit.ly/x5VYML
More Than [40] 5x Picks on "Dawgg".
http://bit.ly/qthbYc
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
